Formation of soluble inclusion bodies by HPV E6 oncoprotein fused to maltose-binding protein

被引:94
作者
Nominé, Y
Ristriani, T
Laurent, C
Lefèvre, JF
Weiss, E
Travé, G [1 ]
机构
[1] Ecole Super Biotechnol Strasbourg, CNRS, UPR 9003, Lab RMN, F-67400 Illkirch Graffenstaden, France
[2] Ecole Super Biotechnol Strasbourg, UPRES 1329, Lab Immunotechnol, F-67400 Illkirch Graffenstaden, France
关键词
HPV oncoprotein E6; fusion protein; protein aggregation; protein overexpression; protein folding;
D O I
10.1006/prep.2001.1451
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Many polypeptides overexpressed in bacteria are produced misfolded and accumulate as solid structures called inclusion bodies. Inclusion-body-prone proteins have often been reported to escape precipitation when fused to maltose-binding protein (MEP). Here, we have examined the case of HPV 16 oncoprotein E6. The unfused sequence of E6 is overexpressed as inclusion bodies in bacteria. By contrast, fusions of E6 to the C-terminus of MBP are produced soluble. We have analyzed preparations of soluble MBP-E6 fusions by using three independent approaches: dynamic light scattering, lateral turbidimetry, and sandwich ELISA. All three methods showed that MBP-E6 preparations contain highly aggregated material. The behavior of these soluble aggregates under denaturating conditions suggests that they are formed by agglomeration of misfolded E6 moieties. However, precipitation is prevented by the presence of the folded and highly soluble MBP moieties, which maintain the aggregates in solution. Therefore, the fact that a protein or protein domain is produced soluble when fused to the C-terminus of a carrier protein does not guarantee that the protein of interest is properly folded and active. We suggest that aggregation of fusion proteins should be systematically assayed, especially when these fusions are to be used for binding measurements or activity tests. (C) 2001 Academic Press.
引用
收藏
页码:22 / 32
页数:11
相关论文
共 35 条
[1]   A MICROTITRE PLATE ELISA TO MEASURE THROMBIN ANTITHROMBIN COMPLEX USING PAN-SPECIFIC ANTIBODIES [J].
BOISCLAIR, MD ;
LANE, DA .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (06) :795-802
[2]  
CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P838
[3]   INTERACTION OF PAPILLOMAVIRUS E6 ONCOPROTEINS WITH A PUTATIVE CALCIUM-BINDING PROTEIN [J].
CHEN, JJ ;
REID, CE ;
BAND, V ;
ANDROPHY, EJ .
SCIENCE, 1995, 269 (5223) :529-531
[4]   DEGRADATION OF P53 CAN BE TARGETED BY HPV E6 SEQUENCES DISTINCT FROM THOSE REQUIRED FOR P53 BINDING AND TRANSACTIVATION [J].
CROOK, T ;
TIDY, JA ;
VOUSDEN, KH .
CELL, 1991, 67 (03) :547-556
[5]   Molecular analysis of the interaction between HPV type 16 E6 and human E6-associated protein [J].
Daniels, PR ;
Sanders, CM ;
Coulson, P ;
Maitland, NJ .
FEBS LETTERS, 1997, 416 (01) :6-10
[6]  
Gao QS, 1999, MOL CELL BIOL, V19, P733
[7]  
Giovane C, 1999, J MOL RECOGNIT, V12, P141, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<141::AID-JMR453>3.0.CO
[8]  
2-O
[9]   LOCALIZATION OF THE E6-AP REGIONS THAT DIRECT HUMAN PAPILLOMAVIRUS E6 BINDING, ASSOCIATION WITH P53, AND UBIQUITINATION OF ASSOCIATED PROTEINS [J].
HUIBREGTSE, JM ;
SCHEFFNER, M ;
HOWLEY, PM .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (08) :4918-4927
[10]   A CELLULAR PROTEIN MEDIATES ASSOCIATION OF P53 WITH THE E6 ONCOPROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-16 OR TYPE-18 [J].
HUIBREGTSE, JM ;
SCHEFFNER, M ;
HOWLEY, PM .
EMBO JOURNAL, 1991, 10 (13) :4129-4135